Mint and Cymbalta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mint (peppermint) and Cymbalta (duloxetine hydrochloride). Common drug interactions include dry mouth among females and chills among males.

The phase IV clinical study analyzes what interactions people have when they take Mint and Cymbalta. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Mint?

Mint has active ingredients of peppermint. eHealthMe is studying from 1,344 Mint users. Check the latest studies of Mint.

What is Cymbalta?

Cymbalta has active ingredients of duloxetine hydrochloride. It is often used in depression. eHealthMe is studying from 154,973 Cymbalta users. Check the latest studies of Cymbalta.



On Jul, 20, 2026

18 people who take Mint and Cymbalta together, and have interactions are studied.

Mint and Cymbalta drug interactions.

What are the common drug interactions of Mint and Cymbalta, by gender? *:

female:

  1. Dry mouth
  2. Euphoric mood (excessively happy but may become angry or irritable)
  3. Herpes virus infection
  4. Memory impairment
  5. Periodic limb movement disorder
  6. Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Therapeutic response decreased (less preventive response)
  9. Tooth disorder (tooth disease)
  10. Tooth fracture

male:

  1. Chills (felling of cold)
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting

What are the common drug interactions of Mint and Cymbalta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Foot fracture
  2. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  3. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  4. Hand fracture
  5. Nausea (feeling of having an urge to vomit)
  6. Osteopenia (a condition where bone mineral density is lower than normal)
  7. Rib fracture

40-49:

  1. Abdominal distension
  2. Euphoric mood (excessively happy but may become angry or irritable)
  3. Fatigue (feeling of tiredness)
  4. Therapeutic response decreased (less preventive response)
  5. Tooth disorder (tooth disease)
  6. Weight fluctuation
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Temporomandibular joint syndrome (pain at the temporomandibular joint due to various causes of increased muscle tension and spasm. it is believed that syndrome is a physical manifestation of psychological stress)

50-59:

  1. Nausea (feeling of having an urge to vomit)
  2. Tooth fracture
  3. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  4. Dyspnoea (difficult or laboured respiration)
  5. Gait disturbance
  6. Gastric disorder (disease of stomach)
  7. Gingival disorder (gum disease)
  8. Headache (pain in head)
  9. Heart rate increased
  10. Influenza like illness

60+:

  1. Diarrhoea
  2. Fall
  3. Limb injury
  4. Loss of consciousness
  5. Nausea (feeling of having an urge to vomit)
  6. Pain in extremity

What are the existing conditions these people have? *

  1. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 8 people, 44.44%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 44.44%
  3. Muscle Spasms (muscle contraction): 3 people, 16.67%
  4. Irritable Bowel Syndrome: 3 people, 16.67%
  5. Neuralgia (pain in one or more nerves): 3 people, 16.67%
  6. Drowsiness: 3 people, 16.67%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 11.11%
  8. Primary Progressive Multiple Sclerosis (primary progressive inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 2 people, 11.11%
  9. Itching: 2 people, 11.11%
  10. Migraine (headache): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Mint and Cymbalta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mint and Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mint:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cymbalta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mint and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cymbalta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on peppermint and duloxetine hydrochloride (the active ingredients of Mint and Cymbalta, respectively), and Mint and Cymbalta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: